Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Barinthus Biotherapeutics (BRNS) over the last 5 years, with Q3 2025 value amounting to 0.0.

  • Barinthus Biotherapeutics' Asset Utilization Ratio fell 9667.0% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 9667.0%. This contributed to the annual value of 0.08 for FY2024, which is 231358.99% up from last year.
  • According to the latest figures from Q3 2025, Barinthus Biotherapeutics' Asset Utilization Ratio is 0.0, which was down 9667.0% from 0.11 recorded in Q2 2025.
  • Over the past 5 years, Barinthus Biotherapeutics' Asset Utilization Ratio peaked at 0.16 during Q4 2022, and registered a low of 0.0 during Q4 2021.
  • For the 5-year period, Barinthus Biotherapeutics' Asset Utilization Ratio averaged around 0.06, with its median value being 0.05 (2022).
  • In the last 5 years, Barinthus Biotherapeutics' Asset Utilization Ratio surged by 1632345.74% in 2022 and then plummeted by 9857.65% in 2024.
  • Barinthus Biotherapeutics' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then skyrocketed by 16323.46% to 0.16 in 2022, then crashed by 97.8% to 0.0 in 2023, then soared by 2276.96% to 0.09 in 2024, then tumbled by 96.9% to 0.0 in 2025.
  • Its last three reported values are 0.0 in Q3 2025, 0.11 for Q2 2025, and 0.1 during Q1 2025.